A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.
Kessler, Jessica D; Kahle, Kristopher T; Sun, Tingting; Meerbrey, Kristen L; Schlabach, Michael R; Schmitt, Earlene M; Skinner, Samuel O; Xu, Qikai; Li, Mamie Z; Hartman, Zachary C; Rao, Mitchell; Yu, Peng; Dominguez-Vidana, Rocio; Liang, Anthony C; Solimini, Nicole L; Bernardi, Ronald J; Yu, Bing; Hsu, Tiffany; Golding, Ido; Luo, Ji; Osborne, C Kent; Creighton, Chad J; Hilsenbeck, Susan G; Schiff, Rachel; Shaw, Chad A; Elledge, Stephen J; Westbrook, Thomas F.
; 335(6066): 348-53, 2012 Jan 20.
Artigo em Inglês | MEDLINE | ID: mdl-22157079
Ubiquitin-activating enzyme is necessary for 17ß-estradiol-induced breast cancer cell proliferation and migration.
PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.
S. pombe Uba1-Ubc15 Structure Reveals a Novel Regulatory Mechanism of Ubiquitin E2 Activity.
Activating the ubiquitin family: UBA6 challenges the field.
Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development.
Functional Proteomics Study Reveals SUMOylation of TFII-I is Involved in Liver Cancer Cell Proliferation.
Effective virtual screening strategy toward covalent ligands: identification of novel NEDD8-activating enzyme inhibitors.
A Comprehensive Bioinformatics Analysis of <i>UBE2C</i> in Cancers.
Structural insights into E1-catalyzed ubiquitin activation and transfer to conjugating enzymes.
Involvement of autophagy in oncogenic K-Ras-induced malignant cell transformation.